Design an AI-enabled software as a medical device that offers cutting-edge capabilities and earns the trust of healthcare professionals, ultimately improving patient care.
Back to team page
Christina Ambrose
Director
With a background in interdisciplinary social sciences, Christina has been trained in various qualitative research methods. Her human factors expertise includes consulting on products from early-stage exploratory research through end stage validation studies, and she has supported several successful submissions. She collaborates with clients to design programs of research and decide on optimal methodologies, while supervising individual research projects involving medical devices and digital health management platforms. Christina holds a BA in Comparative Human Development and an MA in the Social Sciences from the University of Chicago.



Bold facts
Learn more about

Something unique about you summed up in one sentence:

Your favorite part of working at Bold Insight:

In your spare time (or if you had spare time), you would absolutely do this:

Your favorite city in the world is...and why?

You cannot start the day without doing this:

Your ultimate celebrity dinner party guest list would include:

Long-term personal or professional goal?

Any other facts to share?
Read our team’s latest bold insights
Why UX people make great strategy consultants
Learn why UX researchers excel as strategy consultants through data-driven approaches that address critical decisions and adapt to new contexts.
Global UX, mastered: The UXalliance’s 20-year collaboration story
This year marks the 20th anniversary of the UXalliance. To celebrate this milestone, we sat down with Gavin, one of the five founding members, to discuss the organization’s history, guiding principles, and the benefits it brings to clients.
Human factors testing for OTC drugs and non-prescription medical devices
As the field of human factors continues to evolve, so must our approaches to testing and study design. While the FDA’s 2013 guidance laid the groundwork for study design and methodology, recent discussions and conference presentations have prompted a shift in how we approach OTC HF testing, leading to more comprehensive and realistic assessments of these products.